The COVID-19 Antigen Rapid Test is a lateral flow immunoassay based on the principle of double antibody sandwich technology. The SARS-CoV-2 nucleocapsid protein monoclonal antibody conjugated with colored microparticles is used as a detector and sprayed onto the conjugation pad. During the test, the SARS-CoV-2 antigen in the sample interacts with the SARS-CoV-2 antibody, which is conjugated with colored microparticles, creating an antigen-antibody-labeled complex. This complex migrates via capillary action on the membrane to the test line, where it is captured by the pre-coated monoclonal SARS-CoV-2 nucleocapsid protein antibody. A colored test line (T) would be visible in the result window if SARS-CoV-2 antigens are present in the sample. The absence of the T-line indicates a negative result. The control line (C) is used as a procedural control and should always be displayed when the test procedure is being carried out properly.
CE certified (CE 1434)
Sensitivity: 94,5 %
Specificity: 99,9 %
Clear result after less than 10 minutes
Simple and painless application
Fast test result
CE certified and therefore approved throughout Europe CE 1434)
BfArM listed
evaluated by the Paul Ehrlich Institute
reacts to the Omikron mutant
very high reliability
Recognizes a variety of mutations (Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Epsilon (B.1.427 / B.1.429), Delta (B.1.617.2))
